Bar-coded medication labeling: setting the stage for bar-code-enabled point-of-care systems

Area of Science:

• Health Informatics
• Patient Safety
• Pharmaceutical Sciences

Background:

• The U.S. Food and Drug Administration (FDA) mandated bar codes on drug and biological product labels for hospital use.
• Bar-code-enabled point-of-care (BPOC) systems are designed to enhance patient safety by reducing medication errors.
• Effective BPOC implementation relies on the availability of medications in unit-dose packaging.

Purpose of the Study:

• To inform healthcare facilities about the implications of the FDA's final ruling on bar code labeling for drug and biological products.
• To highlight the importance of bar-code-enabled point-of-care (BPOC) systems in preventing medication errors.
• To outline the necessary preparations for hospitals to leverage BPOC technology effectively.

Main Methods:

• Analysis of the FDA's final ruling on drug and biological product labeling.
• Examination of the functionality and benefits of bar-code-enabled point-of-care (BPOC) systems.
• Assessment of the current availability of unit-dose packaging for medications.

Main Results:

• The FDA ruling mandates bar codes on all drug and biological products sold to hospitals, facilitating BPOC system adoption.
• BPOC systems improve medication safety by verifying the right drug for the right patient at the right time.
• Currently, only approximately one-third of medications are available in unit-dose packaging.

Conclusions:

• Hospitals must prepare for widespread BPOC system implementation, which may require in-house or third-party drug repackaging.
• While widespread BPOC adoption may take several years, proactive planning and groundwork are essential.
• The availability of unit-dose packaging is a critical factor for the full effectiveness of BPOC systems.